Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2020

Open Access 01.12.2020 | Research article

Spontaneous conception outcome in infertile women after four-dimensional hysterosalpingo-contrast-sonography

verfasst von: Yu Liu, Ning Zhang, Yanni He, Jiayao Shi, Meijun Zhou, Jingjiao Xu, Hongmei Liu

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2020

Abstract

Background

Four-dimensional hysterosalpingo-contrast sonography (4D-HyCoSy) is the preferred way for evaluating fallopian tubal patency and it associated with higher rate of spontaneous conception. However, Few studies have evaluated the influencing factors of spontaneous conception in 4D-HyCoSy and suggested ways to choose treatment options after 4D-HyCoSy. The study was to evaluate the correlation between spontaneous conception outcome and the patients’ clinical characteristics as well as tubal patency in infertile women to provide reference on ways to manage the patient after 4D-HyCoSy.

Methods

This was a retrospective study and analysis of two hundred and eighty three (283) infertile patients who underwent a 4D-HyCoSy between December 2014 and October 2017 in our center. Eligible patients were those whose partners semen parameters were normal when based on World Health Organization (WHO) criteria, and had spontaneous conception without clinical interventions after 4D-HyCoSy.

Result(s)

One hundred and sixteen patients (40.9%) conceived spontaneously and the mean conception time was (8.8 ± 0.3) months. Within a year after 4D-HyCoSy, the spontaneous conception rate was highest in type VI(62.5%), followed by type IV (46.2%), type III (44.4%), type V (39.4%), type II (33.9%) and type I (14.8%). With Cox regression analysis, two factors associated with spontaneous conception outcome appeared to increase spontaneous conception rate: patients with type IV or type VI tubes and duration of infertility less than 2 years. The age, type of infertility, multiparas, history of pelvic surgery, history of uterine cavity operation, uterine fibromyomata and polycystic ovary were unrelated to spontaneous conception outcome after 4D-HyCoSy.

Conclusion(s)

This study showed that some infertile women could succeed in spontaneous conception after 4D-HyCoSy. Hence, We recommend the usage of 4D-HyCoSy as first line for tubal patency test and infertile patients should be advised to accept 4D-HyCoSy examination as soon as possible. Expectant treatment of about 8–9 months is reported to be feasible for infertile women whose 4D-HyCoSy findings showed one tube patency or poor patency. Alternatively, an immediate clinical intervention is recommended for those with bilateral obstructed tubes .
Hinweise
Yu Liu and Ning Zhang contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
4D-HyCoSy
Four-dimensional hysterosalpingo-contrast sonography
WHO
World Health Organization
LC
Laparoscopy chromopertubation
HSG
Hysterosalpingography
HyFoSy
Hysterosalpingo-foam sonography
2D-HyCoSy
Two-dimensional hysterosalpingo-contrast sonography
3D-HyCoSy
Three-dimensional hysterosalpingo-contrast sonography
IVF
In vitro fertilization

Background

Fallopian tubal Factors accounts for approximately 30 to 35% of infertility among women of childbearing age [13]. Therefore, an accurate evaluation of tubal patency is a fundamental step during clinical management decision-making for infertile women [46].
Laparoscopy chromopertubation (LC) is considered as the gold standard for evaluating tubal patency. However, LC requires general anesthesia and hospitalization [7]. Hysterosalpingography (HSG) is a traditional imaging method to evaluate tubal patency, but its clinical use is limited by the risk of iodine allergy and radiation [6, 8]. Ultrasound evolved from two-dimensional contrast modes to three-dimensional and four-dimensional contrast modes [2]. Conventional two-dimensional hysterosalpingo-contrast sonography (2D-HyCoSy) has limitations in that signals from the total length of the tube and full contour of the uterine cavity have rarely been depicted in a single scanning plane because of tubal tortuosity and limited detection angles of the ultrasound beam [9, 10]. With the introduction of four-dimensional hysterosalpingo-contrast sonography (4D-HyCoSy), a diagnostic accuracy of 87.5–92.9% [2, 3, 11],the use of ultrasound in reproductive field has gradually increased. As opposed to 2D-HyCoSy and three-dimensional hysterosalpingo-contrast sonography (3D-HyCoSy), 4D-HyCoSy enables observation of the entire course of fallopian tube contrast development rather than an instant capture [2, 1214].
Our clinical follow-up data and previous studies showed that some infertile women succeed in spontaneous conception after 4D-HyCoSy. Thus, expectant treatment is recommended to reduce overtreatment and save medical resources due to the therapeutic effects of tubal flushing test [15]. However, Few studies have suggested ways to choose treatment options. i.e., expectant treatment or clinical interventions based on the primary clinical characteristics of infertile women and their evaluation results of 4D-HyCoSy on tubal patency. In addition, few studies have suggested the expectant treatment time after 4D-HyCoSy.
The study aimed to analyze the correlation between the spontaneous conception outcomes of infertile women after 4D-HyCoSy and their underlying clinical conditions as well as the tubal patency, to provide reference on ways to manage the patient after 4D-HyCoSy, as well as carry out further clinical interventions.

Methods

Study area and design

This retrospective study was approved by the Ethics Committee of Guangdong Second Provincial General Hospital (2018-CSkWZ-009). All participants had signed informed consent before examinations.

Patients selection

All the records of the seven hundred and eleven (711) patients who underwent the 4D-HyCoSy in our center between December 2014 and October 2017 were extracted for in depth analysis. Basic clinical data extracted from the records included age, duration of infertility, type of infertility, multipara, previous pelvic inflammatory disease, previous pelvic surgery, previous intrauterine surgery and abortions. In order to determine the spontaneous conception of infertile women after 4D-HyCoSy, it was necessary to select patients who conformed to two major criteria: 1. the patient’s husband showed no evident cause for infertility [16]. 2. No clinical interventions (IVF or hysteroscopy and laparoscopic surgery) were given after 4D-HyCoSy. To conform to these criteria, the exclusion criteria were as follows: women did not conceive without contraception less than a year (35 patients), semen abnormalities (according to WHO 2010 guideline) or no semen examination (213 patients), hydrosalpinx by ultrasound examination (29 patients), hysteroscopy and laparoscopic surgery (103 patients) or in vitro fertilization (IVF) (4 patients) within a year after 4D-HyCoSy, According to the exclusion criteria, 327 patients were enrolled in our follow-up study (Fig. 1).

4D-HyCoSy

A Voluson E8 Expert (GE Healthcare, Zipf, Austria) With RIC5–9-D volume probe (5–9 MHz) was used. Equipment settings for 4 dimensional contrast sonography were as follows: volume box angle at 179°, volume angle at 120°, quality at low, direction at up/down, render mode at gradient light and threshold, Low at < 20, adjusted according to the image [14, 17]. The contrast agent was prepared by adding 5 ml of 0.9% sterile saline solution to 59 mg of SF6 Sonovue freeze-dried powder (Bracco International BV, Amsterdam, the Netherlands), then 2.5 ml SonoVue solution was aspirated and diluted it into a 15 ml suspension with the 0.9% of saline solution.
The 4D-HyCoSy was performed within 3 to 10 days after menstruation. Each examination was performed by an experienced physician with more than 5 years of ultrasonographic diagnosis. The patient was in lithotomy position with her vulva and cervix routinely disinfected with an iodinated solution (Effective iodine content: 0.45–0.55%, Shanghai Likang Disinfection Technology Co., Ltd). The condition of the uterus, ovaries and pelvic cavity was evaluated by 2-dimensional transvaginal sonography and the results were recorded (uterine fibromyoma, uterine cavity lesions such as endometrial polyps or adhesions and polycystic ovaries). Next the 4D-HyCoSy was performed. An appropriate initial plane was selected by positioning the vaginal probe at the level of the sectional plane of the uterus, with slight adjustment to allow visualization of bilateral uterine horns and surrounding tissues. 4D-HyCoSy was activated while keeping the probe at the same position with the region of interest as wide as possible. Fifteen millimeters (15 ml) of the contrast agent earlier prepared was then insufflated and adjusted in accordance with the development in the fallopian tube(s) such as spillage at the fimbriae of the contrast in the pelvis. The contrast agent was passed through the catheter into the uterine cavity, following which the flow of the contrast agent in the fallopian tube and the overflow at the tubal fimbriae were observed. The dynamic enhanced volume images were saved and analyzed after the injection of the contrast medium [2, 11, 14].

Criteria for tubal patency [14] (Fig. 2)

Fallopian tube patency

The contrast agent filled the whole uterine cavity that quickly flowed into the fallopian tube and sprayed at the fimbria of the tube. In addition, the passage of the tube was soft and naturally directed downward.

Poor patency of fallopian tube

The entire fallopian tube and the spillage at the fimbria of the tube were visible, but the passage of the tube was stiff, discontinuous, filamented, angled, circuitous, and directed upward.

Fallopian tube obstruction

Resistance built-up following the injection of the contrast agent. We could not see the entire passage of the tube or the spillage at the fimbria.

Classification of fallopian tube

According to the bilateral tube patency, patients were divided into six categories: type I, defined as bilateral fallopian tubes obstruction; type II, defined as one obstructed fallopian tube with poor patency in the other; type III, defined as one obstructed fallopian tube with patent in the other; type IV, defined as bilateral fallopian tube poor patency; type V, defined as one fallopian tube poor patency with patent in the other; type VI, defined as bilateral fallopian tubes patent.

Outcomes

The outcome of spontaneous conception defined as conception by sexual intercourse and a sonographically visible fetal sac within the uterine cavity. Patients were followed up once a month by telephone, clinical, ultrasound examinations after 4D-HyCoSy. The follow-up lasted for 12 months or till the patient succeeded in the first spontaneous conception.

Statistical analysis

All statistical analyses were conducted with SPSS version 23.0 software for windows (SPSS Inc., Chicago, IL, USA). The data were expressed as \( \overline{x} \) ± SD or percentage. The chi-square test was used to compare the difference among groups for counting data. Kaplan–Meier method was performed to calculate cumulative conception rates and conception time after 4D-HyCoSy. Log-rank test was performed to evaluate the clinical and ultrasound factors on spontaneous conception that included age, duration of infertility, infertility type, previous pelvic surgery, history of abortion, history of intrauterine surgery, history of pelvic inflammatory disease, multiparas or not, uterine fibromyoma, lesion of uterine cavity (adhesions or/and polyps), polycystic ovary and tubal patency. Next, a stepwise Cox regression was performed to analyze the potential confounding affecting factors associated with spontaneous conception, and a P value < 0.05 was considered significant.

Results

Basic characteristics of the patient

A total of seven hundred and eleven (711) patients performed 4D-HyCoSy in this study, and 327 (327/711,46.0%) met the inclusion criteria, Each case was followed up for a year. A total of 44 patients (44/327,13.5%) were lost follow-up, and 283 patients were finally included in our study (Fig. 1). six patients undergo repeated procedure due to severe venous intravasation. No Patients had a severe vasovagal reaction requiring resuscitation. The age of the participants ranged from 20 to 46 years, with an average age of (30.4 ± 5.4) years. The duration of infertility among patients ranged from 1 to 10 years, with a mean of (2.0 ± 1.7) years.

Natural conception outcome

One hundred sixteen (116) infertile women succeeded in spontaneous conception in a year after 4D-HyCoSy and they were carried to term. Also, an ectopic conception occurred. The cumulative conception rate was 40.9% and the mean conception time was (8.8 ± 0.3) months. The conception rate of 1–3 months,1–6 months,1-9 months and 1–12 months was 21.5%, 30.4%, 38.2%, 40.9%, respectively; and the conception rates of 1–3 months, 4–6 months, 7–9 months and 10–12 months accounted for 52.6, 20.7, 19.8 and 6.9% of the total conception rates, respectively.

Factors on spontaneous conception

The three factors (tubal patency, duration of infertility, uterine cavity lesions) selected by univariate analysis were included in multivariate regression analysis. The results showed that spontaneous conception outcome after 4D-HyCoSy was the result of multiple factors, i.e. the spontaneous conception rates increased with decreasing infertility duration and good tubal patency (Table 2). No significant difference was observed in the age, type of infertility, multiparas, history of pelvic surgery, history of pelvic inflammation, abortion, uterine cavity operation, uterine fibromyomata, and polycystic ovary between conception group and non-conception group after 4D-HyCoSy (P > 0.05) (Table 1).
Table 1
Basic characteristics between conception group and non-conception group
Characteristic
Conception
(n = 116)
Non-conception
(n = 167)
P
Age group (n /%)
  
0.155
 <30 years
69 (46.3)
80 (53.7)
 
 30–35 years
28 (35.9)
50 (64.1)
 
 ≧35 years
19 (33.9)
37 (66.1)
 
Infertility type (n/%)
  
0.365
 Primary infertility
52 (32.8)
84 (61.8)
 
 Secondary infertility
64 (43.5)
83 (56.5)
 
Duration of infertility
group (n/%)
  
0.000
 <2 years
83 (52.5) a, b
75 (47.5) a, b
 
 2-3 years
20 (29.4)
48 (70.6)
 
 ≧3 years
13 (22.8)
44 (77.2)
 
History of pelvic
Surgery (n/%)
  
0.505
 yes
18 (36.7)
31 (63.3)
 
 no
98 (41.9)
136 (58.1)
 
History of abortion (n/%)
  
0.420
 yes
40 (44.4)
50 (55.6)
 
 no
76 (39.4)
117 (60.6)
 
History of uterine cavity operation (n/%)
  
0.531
 yes
45 (38.8)
71 (61.2)
 
 no
71 (42.5)
96 (57.5)
 
Multiparas (n/%)
  
0.726
 yes
37 (42.5)
50 (57.5)
 
 no
79 (40.3)
117 (59.7)
 
History of pelvic inflammation (n/%)
  
0.064
 Yes
10 (27.0)
27 (73.0)
 
 No
106 (43.1)
140 (56.9)
 
Polycystic ovary (n/%)
  
0.747
 Yes
19 (41.3)
27 (58.7)
 
 No
104 (43.9)
133 (56.1)
 
lesion of the uterine cavity (n/%)
  
0.042
 yes
13 (27.7)
34 (72.3)
 
 no
103 (43.6)
133 (56.4)
 
Fibromyomata (n/%)
  
0.584
 yes
16 (37.2)
27 (62.8)
 
 no
100 (41.7)
140 (58.3)
 
aDifference in duration of infertility group between < 2 years and ≧3 years
bDifference in duration of infertility group between< 2 years and 2 to 3 years
4D-HyCoSy results suggested that there were 27 cases of type I, 56 cases of type II, 9 cases of type III, 93 cases of type IV, 66 cases of type V, and 32 cases of type VI, respectively. Within a year after 4D-HyCoSy, the spontaneous conception rate was highest in type VI, reaching 62.5%, followed by type IV (46.2%), type III (44.4%), type V (39.4%), type II (33.9%) and type I (14.8%) (P < 0.01) (Figs. 3 and 4). Further comparison between the two groups (Due to the small number of type III, no statistical analysis was performed) showed that the conception rate of type VI significantly exceeded that of type IV and type V. There was no significant difference in conception rate between type IV and type V. Meanwhile, the conception rate of type VI, type IV and type V was significantly higher than that of type I (Fig. 4). Cox regression analysis showed fallopian tube patency was significantly associated with spontaneous conception, and the conception rate of infertile women with type IV and type VI increased significantly after 4D-HyCoSy.The mean conception time was (5.0 ± 2.1) months in type VI, (8.6 ± 0.5) months in type V and (9.0 ± 0.5) months in type IV, respectively.
The conception rate was highest among women who were infertile for less than 2 years (52.5%), followed by duration of infertility ranging 2 to 3 years (29.4%) and the duration of infertility more than or equal to 3 years (22.8%)(P < 0.05) (Table 1 and Fig. 5). Cox regression analysis showed that duration of infertility was significantly associated with spontaneous conception (Table 2). The conception rate of infertile women with duration of infertility less than 2 years increased significantly after 4D-HyCoSy (Table 2). The mean conception time was (8.2 ± 0.4) months in patients with duration of infertility less than 2 years.
Table 2
The influencing factors of spontaneous conception after 4D-HyCoSy
Factors
Kaplan-Meier analysis
Cox regression
HR(95%CI)
P
HR(95%CI)
P
Tubal patency
 Type VI
6.87 (2.35, 20.11)
0.000
6.04 (2.06, 17.75)
0.001
 Type IV
3.8 (1.37, 10.59)
0.011
3.22 (1.15, 9.01)
0.026
 Type III
3.77 (1.01, 14.02)
0.048
3.48 (0.93, 13.02)
0.064
 Type V
3.12 (1.09, 8.95)
0.034
2.59 (0.90, 7.46)
0.077
 Type II
2.51 (0.85, 7.42)
0.095
2.30 (0.78, 6.83)
0.132
Duration of infertility group
 <2 years
2.71 (1.51, 4.87)
0.001
2.76 (1.53, 4.97)
0.001
 2-3 years
1.37 (0.68, 2.76)
0.375
1.46 (0.72, 2.94)
0.293
Disease of the uterine cavity
 no
1.74 (0.98, 3.09)
0.061
1.69 (0.94, 3.03)
0.079
HR Hazard ratio, CI Confidential interval
Tubal patency group was compared with type I group. Duration of infertility group was compared with duration of infertility more than or equal to 3 years. Disease of the uterine cavity group was compared with those without. Type I, defined as both fallopian tubes obstructed, Type II, defined as one fallopian tube obstructed with poor patency in the other; type III, defined as one fallopian tube obstructed with patent in the other; type IV, defined as both fallopian tubes poor patency; type V, defined as one fallopian tube poor patency with patent in the other; type VI, defined as both fallopian tubes patent
The conception rate was significantly low in women with lesion of uterine cavity (endometrial polyp or adhesion of uterine cavity) (Table 1).

Discussion

Our study demonstrated that some infertile women could succeed in spontaneous conception after 4D-HyCoSy and their conception rates could be up to 40.9%. The mean conception time was (8.8 ± 0.3) months within a year after 4D-HyCoSy. This may be an indication that infertile women could have expectant treatment for a certain time to reduce overtreatment and clinical risks. The positive effect of 4D-HyCoSy is probably due to mechanical action of the contrast agent. The passage of liquid breaks up minor adhesion within the tubes [4, 15].
The conception rate of infertile women within a year after 4D-HyCoSy was higher than those reported by Chunyan Gao et al. (40.9% vs. 26.59%) [15]. There may be two reasons. Firstly, this may due to the fact that we excluded some infertile patients with semen abnormalities of their husbands. Secondly, it is the relatively large proportion of bilateral tube patency (67.5% vs. 62.0%) and small proportion of bilateral tube obstruction (9.5% vs. 13.2%) in our study. In addition, the incidence of spontaneous conception in a year after 4D-HyCoSy in our study was higher than those who accepted hysterosalpingo-foam sonography (HyFoSy) used ExEm-gel (40.9% vs. 19%) [18]. On the other hand, the incidence of conception rate in a year after tubal flushing among those who accepted HSG used oil contrast (32.1%) or water contrast (23.6%) was relatively lower than our study (40.9%) [19]. Our results showed that the mean conception time was (8.8 ± 0.3) months within a year after 4D-HyCoSy, which indicated that some infertile women could succeed in spontaneous conception within a short time after 4D-HyCoSy. Furthermore, we found out that fallopian tubes patency was significantly associated with spontaneous conception, which is consistent with the previous studies [4, 15]. These studies suggested that infertile women with type VI should be considered at least 5 months for expectant treatment, whereas 9 months is typical for type IV and type V infertile women.
In our study, there were only 9 women with type III tubes, and their conception rate reached 44.4%. In this group, women with infertility who succeed in achieving spontaneous conception had short duration of infertility, mostly about 1 year. Therefore, for infertile women with one tube obstruction but short duration of infertility, 8 to 9 months of expectant treatment should be considered.
Theoretically, it was challenging to achieve spontaneous conception among type I infertile patients, and therefore, clinical interventions was necessary [20]. Our study included exceptional cases, i.e. Four infertile patients achieved spontaneous conception, probably due to the passage of liquid through the tube that removed the buildup of debris inside it, and the other might be due to the false-positive results of tubal spasm during 4D-HyCoSy.
Regression analysis showed that short duration of infertility (less than 2 years) was significantly associated with spontaneous conception after 4D-HyCoSy, which was consistent with published studies [4]. The reason might be that long-term tubal obstruction caused by chronic inflammatory reaction damaged the internal structures including the cilia, and made it difficult to achieve spontaneous conception [21]. Therefore, we strongly recommend that infertile women should undergo 4D-HyCoSy examination as early as possible. Alternatively, infertile women with duration of infertility less than 2 years after 4D-HyCoSy can consider about 8 to 9 months of expectant treatment.
However, our study has two significant limitations. We did not compare the spontaneous conception rate of infertile women who did not undergo 4D-HyCoSy in outpatient clinics or underwent immediate clinical management (laparoscopic surgery, assisted reproduction treatment) after 4D-HyCoSy, which need further research in future.
The clinical importance of our results is that some infertile patients could undergo expectant treatment for a certain time after 4D-HyCoSy, which could reduce overtreatment and clinical risks and save medical resources.

Conclusions

This study showed that some infertile women could achieve spontaneous conception after 4D-HyCoSy. Hence, We recommend the usage of 4D-HyCoSy as first line for tubal patency test and infertile patients should be advised to accept 4D-HyCoSy examination as soon as possible. Expectant treatment of about 8–9 months is reported to be feasible for infertile women whose 4D-HyCoSy findings showed one tube patency or poor patency. Alternatively, an immediate clinical intervention is recommended for those with bilateral obstructed tubes .

Acknowledgements

We acknowledge the help from Pingyan Chen, Ying Guan, and Lizhi Zhou from the Department of Biostastics in Southern Medical University for the statistical analysis.
This retrospective study was approved by the Ethics Committee of Guangdong Second Provincial General Hospital (2018-CSkWZ-009). All participants had signed informed consent before examinations.
Not applicable.

Competing interests

The authors declare that they have no conflicts of the interest and nothing to disclose.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Hajishafiha M, Zobairi T, Zanjani VR, Ghasemi-Rad M, Yekta Z, Mladkova N. Diagnostic value of sonohysterography in the determination of fallopian tube patency as an initial step of routine infertility assessment. J Ultrasound Med. 2009;28(12):1671–7.CrossRef Hajishafiha M, Zobairi T, Zanjani VR, Ghasemi-Rad M, Yekta Z, Mladkova N. Diagnostic value of sonohysterography in the determination of fallopian tube patency as an initial step of routine infertility assessment. J Ultrasound Med. 2009;28(12):1671–7.CrossRef
2.
Zurück zum Zitat He Y, Geng Q, Liu H, Han X. First experience using 4-dimensional hysterosalpingo-contrast sonography with SonoVue for assessing fallopian tube patency. J Ultrasound Med. 2013;32(7):1233–43.CrossRef He Y, Geng Q, Liu H, Han X. First experience using 4-dimensional hysterosalpingo-contrast sonography with SonoVue for assessing fallopian tube patency. J Ultrasound Med. 2013;32(7):1233–43.CrossRef
3.
Zurück zum Zitat Chen F, Quan J, Huang P, You X. Hysterosalpingo-contrast Sonography with four-dimensional technique for screening fallopian tubal patency: Let's make an exploration. J Minim Invasive Gynecol. 2017;24(3):407–14.CrossRef Chen F, Quan J, Huang P, You X. Hysterosalpingo-contrast Sonography with four-dimensional technique for screening fallopian tubal patency: Let's make an exploration. J Minim Invasive Gynecol. 2017;24(3):407–14.CrossRef
4.
Zurück zum Zitat Giugliano E, Cagnazzo E, Bazzan E, Patella A, Marci R. Hysterosalpingo-contrast sonography: is possible to quantify the therapeutic effect of a diagnostic test? Clin Exp Reprod Med. 2012;39(4):161–5.CrossRef Giugliano E, Cagnazzo E, Bazzan E, Patella A, Marci R. Hysterosalpingo-contrast sonography: is possible to quantify the therapeutic effect of a diagnostic test? Clin Exp Reprod Med. 2012;39(4):161–5.CrossRef
5.
Zurück zum Zitat Mandia L, Personeni C, Antonazzo P, Angileri SA, Pinto A, Savasi V. Ultrasound in. Infertility. Setting: Optimal strategy to evaluate the assessment of Tubal Patency. Biomed Res Int. 2017;2017:3205895.CrossRef Mandia L, Personeni C, Antonazzo P, Angileri SA, Pinto A, Savasi V. Ultrasound in. Infertility. Setting: Optimal strategy to evaluate the assessment of Tubal Patency. Biomed Res Int. 2017;2017:3205895.CrossRef
6.
Zurück zum Zitat Rajesh H, Lim SL, Yu SL. Hysterosalpingo-foam sonography: patient selection and. Perspectives. Int J Women's Health. 2017;9:23–32.CrossRef Rajesh H, Lim SL, Yu SL. Hysterosalpingo-foam sonography: patient selection and. Perspectives. Int J Women's Health. 2017;9:23–32.CrossRef
7.
Zurück zum Zitat Promberger R, Simek IM, Nouri K, Obermaier K, Kurz C, Ott J. Accuracy of tubal patency assessment in diagnostic hysteroscopy compared with laparoscopy in infertile women: a retrospective cohort study. J Minim Invasive Gynecol. 2018;25(5):794–9.CrossRef Promberger R, Simek IM, Nouri K, Obermaier K, Kurz C, Ott J. Accuracy of tubal patency assessment in diagnostic hysteroscopy compared with laparoscopy in infertile women: a retrospective cohort study. J Minim Invasive Gynecol. 2018;25(5):794–9.CrossRef
8.
Zurück zum Zitat Saunders RD, Shwayder JM, Nakajima ST. Current methods of tubal patency assessment. Fertil Steril. 2011;95(7):2171–9.CrossRef Saunders RD, Shwayder JM, Nakajima ST. Current methods of tubal patency assessment. Fertil Steril. 2011;95(7):2171–9.CrossRef
9.
Zurück zum Zitat Kiyokawa K, Masuda H, Fuyuki T, Koseki M, Uchida N, Fukuda T, Amemiya K, Shouka K, Suzuki K. Three-dimensional hysterosalpingo-contrast sonography (3D-HyCoSy) as an outpatient procedure to assess infertile women: a pilot study. Ultrasound Obstet Gynecol. 2000;16(7):648–54.CrossRef Kiyokawa K, Masuda H, Fuyuki T, Koseki M, Uchida N, Fukuda T, Amemiya K, Shouka K, Suzuki K. Three-dimensional hysterosalpingo-contrast sonography (3D-HyCoSy) as an outpatient procedure to assess infertile women: a pilot study. Ultrasound Obstet Gynecol. 2000;16(7):648–54.CrossRef
10.
Zurück zum Zitat Zhou L, Zhang X, Chen X, Liao L, Pan R, Zhou N, Di N. Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency. Ultrasound Obstet Gynecol. 2012;40(1):93–8.CrossRef Zhou L, Zhang X, Chen X, Liao L, Pan R, Zhou N, Di N. Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency. Ultrasound Obstet Gynecol. 2012;40(1):93–8.CrossRef
11.
Zurück zum Zitat He Y, Ma X, Xu J, Li S, Wu H, Liu Q, Kong L, Luo J, Liu H. Comparison of assessment methods for fallopian tubal patency and Peritubal adhesion between Transvaginal 4-dimensional Hysterosalpingo-contrast Sonography and laparoscopic Chromopertubation. J Ultrasound Med. 2017;36(3):547–56.CrossRef He Y, Ma X, Xu J, Li S, Wu H, Liu Q, Kong L, Luo J, Liu H. Comparison of assessment methods for fallopian tubal patency and Peritubal adhesion between Transvaginal 4-dimensional Hysterosalpingo-contrast Sonography and laparoscopic Chromopertubation. J Ultrasound Med. 2017;36(3):547–56.CrossRef
12.
Zurück zum Zitat Wang W, Zhou Q, Gong Y, Li Y, Huang Y, Chen Z. Assessment of fallopian tube Fimbria patency with 4-dimensional Hysterosalpingo-contrast Sonography in infertile women. J Ultrasound Med. 2017;36(10):2061–9.CrossRef Wang W, Zhou Q, Gong Y, Li Y, Huang Y, Chen Z. Assessment of fallopian tube Fimbria patency with 4-dimensional Hysterosalpingo-contrast Sonography in infertile women. J Ultrasound Med. 2017;36(10):2061–9.CrossRef
13.
Zurück zum Zitat Li H, Zhang M, Qiang Y, Ma Y, Mao S, Zhang H. Pain and side effects associated with 4-dimensional hysterosalpingo-contrast sonography for evaluating of the fallopian tubes patency. Comput Assist Surg (Abingdon). 2017;22(sup1):93–9.CrossRef Li H, Zhang M, Qiang Y, Ma Y, Mao S, Zhang H. Pain and side effects associated with 4-dimensional hysterosalpingo-contrast sonography for evaluating of the fallopian tubes patency. Comput Assist Surg (Abingdon). 2017;22(sup1):93–9.CrossRef
14.
Zurück zum Zitat Shi J, Li S, Wu H, He Y, Yi W, Xu J, Liu H, Guan Y. The influencing factors of venous Intravasation during Transvaginal four-dimensional Hysterosalpingo-contrast Sonography with SonoVue. Ultrasound Med Biol. 2019;45(9):2273–80.CrossRef Shi J, Li S, Wu H, He Y, Yi W, Xu J, Liu H, Guan Y. The influencing factors of venous Intravasation during Transvaginal four-dimensional Hysterosalpingo-contrast Sonography with SonoVue. Ultrasound Med Biol. 2019;45(9):2273–80.CrossRef
15.
Zurück zum Zitat Chunyan G, Bin P, Ping Y, Yue Z, Yang X, Hongju T, Li S, Xi X. Assessment of the. Influence on Spontaneous Pregnancy of Hysterosalpingo-Contrast Sonography. Biomed Res Int. 2018;2018:4901281.CrossRef Chunyan G, Bin P, Ping Y, Yue Z, Yang X, Hongju T, Li S, Xi X. Assessment of the. Influence on Spontaneous Pregnancy of Hysterosalpingo-Contrast Sonography. Biomed Res Int. 2018;2018:4901281.CrossRef
16.
Zurück zum Zitat Lindborg L, Thorburn J, Bergh C, Strandell A. Influence of HyCoSy on spontaneous pregnancy: a randomized controlled trial. Hum Reprod. 2009;24(5):1075–9.CrossRef Lindborg L, Thorburn J, Bergh C, Strandell A. Influence of HyCoSy on spontaneous pregnancy: a randomized controlled trial. Hum Reprod. 2009;24(5):1075–9.CrossRef
17.
Zurück zum Zitat He Y, Wu H, Xiong R, Liu H, Shi J, Xu J, Zhang N, Liu Y. Intravasation affects the diagnostic image quality of Transvaginal 4-dimensional Hysterosalpingo-contrast Sonography with SonoVue. J Ultrasound Med. 2019;38(8):2169–80.CrossRef He Y, Wu H, Xiong R, Liu H, Shi J, Xu J, Zhang N, Liu Y. Intravasation affects the diagnostic image quality of Transvaginal 4-dimensional Hysterosalpingo-contrast Sonography with SonoVue. J Ultrasound Med. 2019;38(8):2169–80.CrossRef
18.
Zurück zum Zitat Emanuel MH, van Vliet M, Weber M, Exalto N. First experiences with hysterosalpingo-foam sonography (HyFoSy) for office tubal patency testing. Hum Reprod. 2012;27(1):114–7.CrossRef Emanuel MH, van Vliet M, Weber M, Exalto N. First experiences with hysterosalpingo-foam sonography (HyFoSy) for office tubal patency testing. Hum Reprod. 2012;27(1):114–7.CrossRef
19.
Zurück zum Zitat Fang F, Bai Y, Zhang Y, Faramand A. Oil-based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2018;110(1):153–60.CrossRef Fang F, Bai Y, Zhang Y, Faramand A. Oil-based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2018;110(1):153–60.CrossRef
20.
Zurück zum Zitat Practice Committee of the American Society for Reproductive M. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril. 2015;103(6):e37–43.CrossRef Practice Committee of the American Society for Reproductive M. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril. 2015;103(6):e37–43.CrossRef
21.
Zurück zum Zitat Al-Omari MH, Obeidat N, Elheis M, Khasawneh RA, Gharaibeh MM. Factors affecting pregnancy rate following fallopian tube recanalization in women with proximal fallopian tube obstruction. J Clin Med. 2018;7(5):110.CrossRef Al-Omari MH, Obeidat N, Elheis M, Khasawneh RA, Gharaibeh MM. Factors affecting pregnancy rate following fallopian tube recanalization in women with proximal fallopian tube obstruction. J Clin Med. 2018;7(5):110.CrossRef
Metadaten
Titel
Spontaneous conception outcome in infertile women after four-dimensional hysterosalpingo-contrast-sonography
verfasst von
Yu Liu
Ning Zhang
Yanni He
Jiayao Shi
Meijun Zhou
Jingjiao Xu
Hongmei Liu
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2020
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-020-03315-x

Weitere Artikel der Ausgabe 1/2020

BMC Pregnancy and Childbirth 1/2020 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.